Home / Inspections / 1122418

FDA Inspection 1122418 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 1670014

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on March 19, 2020 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 19, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical BA/BE

Facility

Other inspections at this facility

  • 1270526 (NAI Thu Sep 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1220144 (NAI Fri Sep 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064728 (NAI Mon Aug 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 960316 (NAI Wed Feb 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 949237 (NAI Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources